7-Methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde

Catalog No.: 
ACXHJM824
CAS No.: 
1501213-61-1
Molecular Formula: 
C8H7N3O
Molecular Weight: 
161.16
7-Methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$253.00InquiryInquiry
250mg98%$428.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde
IUPAC Name7-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde
MDL No.MFCD22370976
Molecular FormulaC8H7N3O
Molecular Weight161.16
SMILESO=CC1=CN(C)C2=NC=NC=C21
InChI KeyDIRGTJQJSJSFEH-UHFFFAOYSA-N
Synonym7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE;7H-Pyrrolo[2,3-d]pyrimidine-5-carboxaldehyde, 7-methyl-
CAS No.1501213-61-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXHJM824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSCBR031 route compound structure diagram
    ACSCBR0311638771-55-7In Stock
  2. Then
  3. ACXHJM824 route product structure diagram
    ACXHJM8241501213-61-1
Inquiry

2. ACXHJM824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQAST560 route compound structure diagram
    ACQAST5601638761-56-4In Stock
  4. Then
  5. ACXHJM824 route product structure diagram
    ACXHJM8241501213-61-1
Inquiry

3. ACXHJM824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXHJM824 route product structure diagram
    ACXHJM8241501213-61-1
Inquiry

Comments (0)